SCHEMBL7182277

SCHEMBL7182277

C=CC(=O)OC12CC1C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23494117 0.77
SCHEMBL12791695 0.76
SCHEMBL20656583 0.75 TSHR (0.33)
SCHEMBL1592333 0.74 NAAA (0.33)
SCHEMBL4331183 0.74 MEN1 (0.31)
SCHEMBL12791706 0.74 CYP3A4 (0.31)
SCHEMBL12791684 0.74 CYP3A4 (0.31)
SCHEMBL6545295 0.74 CYP3A4 (0.31)
SCHEMBL258764 0.73
SCHEMBL454650 0.72 THRB (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0100066-B1 SURFACTANT-CONTAINING FILLED AND PLASTICIZED THERMOPLASTIC COMPOSITIONS BASED ON ETHYLENE INTERPOLYMERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1986-03-12 EP claimed
US-10793707-B2 Composition with balance of dissipation factor and additive acceptance DOW GLOBAL TECHNOLOGIES LLC (US) 2020-10-06 US disclosed
US-20190270870-A1 Composition with Balance of Dissipation Factor and Additive Acceptance DOW CHEMICAL (CHINA) INVESTMENT COMPANY LIMITED (CN) 2019-09-05 US disclosed
US-10385078-B2 Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-YL) piperidin-1-YL]phenyl}pyrimidine-2,4-diamine ARIAD PHARMACEUTICALS, INC. (US) 2019-08-20 US disclosed
US-20180037597-A1 CRYSTALLINE FORMS OF 5-CHLORO-N4-[-2-(DIMETHYLPHOSPHORYL) PHENYL]-N2-{2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL) PIPERIDIN-1-YL] PYRIMIDINE-2,4-DIAMINE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-02-08 US disclosed
EP-2663553-B1 QUINOLINE AND ISOQUINOLINE DERIVATIVES FOR USE AS JAK MODULATORS AMBIT BIOSCIENCES CORP (US) 2015-08-26 EP disclosed
EP-2532659-A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy Pathway Therapeutics, Inc. (US) 2012-12-12 EP disclosed
US-6572959-B1 RF-sealable pillow pouch CRYOVAC, INC. 2003-06-03 US disclosed
EP-0115905-B1 DIMENSIONALLY HEAT RECOVERABLE ARTICLE RAYCHEM LIMITED (GB) 1988-09-14 EP disclosed